American Well Co. (NYSE:AMWL) Insider Phyllis Gotlib Sells 4,781 Shares

American Well Co. (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 4,781 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $8.80, for a total transaction of $42,072.80. Following the sale, the insider now owns 147,998 shares of the company's stock, valued at approximately $1,302,382.40. This represents a 3.13 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Phyllis Gotlib also recently made the following trade(s):

• On Monday, February 3rd, Phyllis Gotlib sold 299 shares of American Well stock. The stock was sold at an average price of $10.51, for a total value of $3,142.49.

American Well Stock Down 2.9 %

AMWL stock traded down $0.25 during trading on Friday, hitting $8.30. 50,426 shares of the company's stock traded hands, compared to its average volume of 75,476. The firm has a market capitalization of $129.56 million, a P/E ratio of -0.59 and a beta of 1.18. The business has a fifty day simple moving average of $9.88 and a two-hundred day simple moving average of $9.33. American Well Co. has a 1 year low of $5.00 and a 1 year high of $21.60.

American Well (NYSE:AMWL - Get Free Report) last announced its earnings results on Wednesday, February 12th. The company reported ($2.77) earnings per share for the quarter, beating the consensus estimate of ($3.04) by $0.27. American Well had a negative net margin of 81.83% and a negative return on equity of 56.73%. On average, equities research analysts predict that American Well Co. will post -9.34 EPS for the current fiscal year.

Remove Ads

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of American Well in a report on Thursday, February 13th. Truist Financial increased their price target on shares of American Well from $10.00 to $12.00 and gave the company a "hold" rating in a report on Friday, February 14th. Morgan Stanley lowered their price target on shares of American Well from $20.00 to $10.50 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. Wells Fargo & Company raised shares of American Well from an "equal weight" rating to an "overweight" rating and set a $15.00 price objective on the stock in a research report on Monday, January 13th. Finally, Stifel Nicolaus increased their price objective on shares of American Well from $9.00 to $10.00 and gave the stock a "hold" rating in a research report on Thursday, February 13th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $11.90.

Institutional Investors Weigh In On American Well

Several institutional investors and hedge funds have recently made changes to their positions in AMWL. Compagnie Lombard Odier SCmA acquired a new stake in shares of American Well during the fourth quarter worth $45,000. OMERS ADMINISTRATION Corp purchased a new position in American Well in the fourth quarter valued at $76,000. BNP Paribas Financial Markets purchased a new stake in shares of American Well during the third quarter worth about $95,000. PDT Partners LLC purchased a new stake in shares of American Well during the third quarter worth about $107,000. Finally, Corton Capital Inc. purchased a new stake in shares of American Well during the fourth quarter worth about $134,000. 56.05% of the stock is currently owned by institutional investors and hedge funds.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.